SUMMARY A problem in accurately measuring regional myocardial blood flow by radiation washout techniques is the inability to localize precisely the origin of radiation in tissue. We developed a new approach for in vivo localization and quantification of regional blood flow. A miniature, silicon, solid-state, avalanche radiation detector, which measures the low-penetrating radiation from commonly available radionuclides, was constructed. Low-penetrating radiation has a limited range in tissue, and by selecting appropriate tracers, we vary the volume that our probe detects. The volume of the heart monitored by the avalanche probe ranges from less than 0.01 to 1 cm3, depending on the radionuclide used and the collimator design. In open-chest dogs, 2-5 mCi of xenon-133 dissolved in saline were injected into coronary arteries and the probe was placed over regions of interest to measure regional myocardial blood flow by the Kety-Schmidt formula. Detection of xenon-133 decreased as an exponential function of distance, with less than 10% of radioactivity detected at 0.6 cm away from the radiation source. The measured detection volume for xenon-133 was approximated at 0.5 cm3. Measurements of regional blood flow with the probe correlated closely to epicardial flow measured with radioactive microspheres (r = 0.88 ± 0.04 [SDI) 13 We took a different approach to localizing radiation for the quantification of regional myocardial blood by measuring radiation that has a very limited range in tissue. Radionuclides often used in nuclear medicine emit a range of photon energies, only some of which are measured by conventional gamma detectors. Usually, gamma detection measures photons that are of relative high energy and therefore penetrate tissue. However, these isotopes also emit lowpenetrating radiation consisting of lower-energy photon radiation and beta rays that have not been extensively used in clinical or experimental in vivo investigations (table 1) . Low-energy photons and beta rays travel only relatively short distances in tissue, and therefore are usually not detected by gamma detectors located away from the source (figs. 1 and 2).
SUMMARY A problem in accurately measuring regional myocardial blood flow by radiation washout techniques is the inability to localize precisely the origin of radiation in tissue. We developed a new approach for in vivo localization and quantification of regional blood flow. A miniature, silicon, solid-state, avalanche radiation detector, which measures the low-penetrating radiation from commonly available radionuclides, was constructed. Low-penetrating radiation has a limited range in tissue, and by selecting appropriate tracers, we vary the volume that our probe detects. The volume of the heart monitored by the avalanche probe ranges from less than 0.01 to 1 cm3, depending on the radionuclide used and the collimator design. In open-chest dogs, 2-5 mCi of xenon-133 dissolved in saline were injected into coronary arteries and the probe was placed over regions of interest to measure regional myocardial blood flow by the Kety-Schmidt formula. Detection of xenon-133 decreased as an exponential function of distance, with less than 10% of radioactivity detected at 0.6 cm away from the radiation source. The measured detection volume for xenon-133 was approximated at 0.5 cm3. Measurements of regional blood flow with the probe correlated closely to epicardial flow measured with radioactive microspheres (r = 0.88 ± 0.04 [SDI) in five dogs, and to proximal coronary flow measured with electromagnetic meters (r = 0.87 ± 0.05) in five dogs. Repetitive measurements during stable hemodynamics were reproducible. Thus, with avalanche detectors we obtained reliable and valid in vivo measurements of myocardial blood flow from small volumes.
THE COMPREHENSIVE investigation of myocardial microcirculatory regulation has been limited by restrictions in techniques of measuring regional blood flow. No method is suited for rapid, repetitive, accurate, in vivo determination of regional myocardial blood flow. Coronary arteriography, although useful in defining anatomy, does not measure the physiologic significance of obstructions on distal capillary blood flow." 2 Venous sampling techniques depend on adequate coronary sinus sampling and cannot be used for studying highly regionalized events.8 4 The radioactive microsphere technique, although useful in experimental work, allows only a limited number of measurements and requires myocardial biopsy, which is not applicable to the clinical setting. 5 6 Recently, single-crystal Doppler probes have been used to measure blood velocity in small vessels and the physiologic significance of coronary obstruction in animals and man.7 8 However, these devices measure arterial blood velocity rather than more distal capillary blood flow and have limitations in application." Residuecounting techniques using intracoronary injections of radioindicators have been used successfully for quantifying regional myocardial blood flow.9' 10 However, a basic limitation of external counting is the determination of the origin and limits of the radiation. Although more precise localization of radiation is possible with tomography, including transaxial tomography using positron-emitting radionuclides,"' 12 these techniques require expensive instrumentation and have limitations in quantifying measurements of regional blood flow in the experimental or clinical setting. 13 We took a different approach to localizing radiation for the quantification of regional myocardial blood by measuring radiation that has a very limited range in tissue. Radionuclides often used in nuclear medicine emit a range of photon energies, only some of which are measured by conventional gamma detectors. Usually, gamma detection measures photons that are of relative high energy and therefore penetrate tissue. However, these isotopes also emit lowpenetrating radiation consisting of lower-energy photon radiation and beta rays that have not been extensively used in clinical or experimental in vivo investigations (table 1) . Low-energy photons and beta rays travel only relatively short distances in tissue, and therefore are usually not detected by gamma detectors located away from the source (figs. 1 and 2).
Avalanche radiation detectors were developed to detect electromagnetic radiation in the energy range from the x-ray region to infrared. These detectors are ideally suited for detection of low-penetrating, shortrange radiation, and are relatively insensitive to gamma radiation."4 Accordingly, precise localization of radiation is feasible because radiations with limited range in tissue are preferentially measured.
We have applied the first avalanche radiation detector suitable for in vivo biomedical use to the highly localized measurement of regional myocardial blood flow.
Methods
Avalanche Detector Assembly Attempts to use avalanche detectors have been hampered by large variations in gain within different regions of the detector that resulted from nonuniformities in the silicon. This limitation was overcome by the use of neutron transmutation doping, which produced a highly uniform starting material.' This Commonly used radionuclides listed in the first column emit low-penetrating radiation. Positron emitters are also low-penetrating. material was deep gallium diffused to form a PN junction, the silicon was specially processed to eliminate surface instability, and devices were fitted into specially designed aluminum housings (Avalanche Nuclear Inc.).
Principles of Avalanche Radiation Detectors
The front of the device has a weak electric field that causes electrons generated from the radiation interactions of x-rays or charged particles to drift toward the back of the device ( fig. 3 ). When these electrons come under the influence of the strong field located near the PN junction, their velocity increases and they Drift region FIGURE 3. Cross-sectional schematic of an avalanche radiation detector. Incident x-ray or charged particle interacting in thefront ofthe detector (left) results in a cascading, multiplying effect similar to an avalanche. This avalanche internal gain obviates the needfor probe-mounted preamplifiers and enhances the potential for miniaturization. The thin detection region and the low atomic number of silicon combine to make the probe insensitive to highenergy gamma radiation.
flow. The catheter was filled with heparin and the dog was anticoagulated with 3 mg/kg of heparin. In some dogs, a catheter was placed in the left atrium for later injection of radioactive microspheres. In five dogs, the mid-left anterior coronary artery distal to the tubing was isolated, and an occlusion was produced by tying off the vessel with a silk (00) suture. If collateral flow from the circumflex or posterior descending artery was extensive, additional distal vessels were occluded until a well-defined area of ischemia and hypoperfusion could be identified by gross inspection. One hour after coronary occlusion, measurements obtained with the avalanche probe from multiple regions were compared with measurements made with radioactive microspheres. We previously showed that regional myocardial blood flow 1 hour after coronary occlusion correlates with the extent of infarction determined 24 hours later.s1
In five dogs, experiments involving reactive hyperemia were performed. A balloon occluder was used instead of a silk suture to produce temporary occlusions without damage to the vessel. Systemic blood pressure was monitored from a catheter placed in the femoral artery. Pressures were measured with Statham P23Db transducers and hemodynamics were recorded.
Preparation of Xenon-133
A solution of xenon-133 (133Xe) gas in normal saline was produced by crushing a glass ampule containing 1 Ci of '13Xe gas at 1.5-22 mm Hg in a sealed stainless steel cylinder that had been flooded with degassed normal saline. The system was allowed to equilibrate at 2°C overnight. The resulting solution contained as much as 20 mCi of 135Xe/ml.
Determination of Regional Blood Flow
The probe was either held manually on a region of interest or more permanently attached to the surface of the heart by suturing the device directly to the myocardium. Proximal coronary artery injections of 2-5 mCi of '31Xe dissolved in saline were accomplished through the catheter previously placed in the left anterior descending coronary artery.
The signal received from the probe was amplified (ORTEC models 109 PC and 450) and recorded on a Beckman 1005 recorder. This equipment was mounted on a portable cart and all electrical power requirements were interfaced through an electronic isolator. Curves were digitally converted and data entered into a Data General Nova 2-10 computer for curve fitting and calculation of blood flow. Myocardial blood flow for tissue was calculated using the Kety-Schmidt formula, F = K*X/p, where F = myocardial blood flow in ml/min/g, X = the blood myocardium partition coefficient for xenon (0.72), p = the specific gravity of myocardial tissue (1.05), and K = the rate constant of xenon clearance from myocardium determined from the first 40 seconds of clearance by a monoexponential equation using the least-squares method.'7 18 Some investigators have started calculations from peak flow, and others from less than peak flow; we compared blood flow measurements from calculations starting at peak and 85% of peak.
Reliability of Measurements
To determine reliability of measurements, repetitive injections of 133Xe were performed in three dogs with the probe placed in the same location and various degrees of coronary obstruction maintained with a balloon occluder. To ensure stability of the preparation, systemic arterial pressure and coronary arterial blood flow were continuously monitored.
Heart Volume Monitored by the Avalanche Detector
The volume monitored by a detector placed on the surface of the heart depends on the detector, the characteristic emissions of the radionuclide, its distribution in the heart, and the collimator dimensions.
Key detector measurements include the frontal area and the counting efficiency. The intrinsic photon efficiency was calculated from the expression 100 (I -e-t). The effective interaction distance, t, is taken as the depth of the P layer and is known to be about 75 A. The photon cross section for silicon (A) was taken from Strom and Israel.'0 Measurements were made of monoenergetic electrons to determine the detection efficiency for d and positron radiation. Detection volume was also estimated from experiments where measurements were made over a site in which 133Xe dissolved in saline had been injected subcutaneously into 0.2-cm layers of arrested heart muscle.
Relationship to Electromagnetic Blood Flow
Simultaneous measurements with the electromagnetic meter and the avalanche radiation detector were obtained from one location before, during and after coronary stenosis of varying duration (1-60 minutes). Electromagnetic flow was averaged for the period of data acquisition required to determine the disappearance rate of "'Xe. In dogs with permanent occlusion, the probe was placed over locations of ischemic, border and normal areas 1 hour after occlusion, and multiple myocardial blood flow measurements with "33Xe were obtained. Each location was carefully recorded and identified by exact relationship to various arteries and anatomic landmarks.
After measurements of regional myocardial blood flow with 13'Xe were completed, radioactive microspheres labeled with "'Cerium or 85Strontium (3M) were thoroughly mixed in a vortex mixer and 1-2 x 106 microspheres were injected into the left atrial catheter. A reference flow from the arterial catheter was started a few seconds before injection and collected for 3 minutes. After microsphere injections, the dogs were killed with an overdose of barbiturates and the hearts were excised. Multiple 0.3-g epicardial biopsies in exactly the same location where the "'Xe measurements were performed were obtained with a punch drill. Blood flow was calculated as previously described and expressed as ml/min/g.'6' 20
Statistics
The mean, standard deviation, standard error of the mean, nonpaired t test, correlation coefficient and monoexponential fit of each washout curve were performed on a Data General Nova 2-10 computer.
Results
Probe Assembly
The probe was manufactured specifically for use in open-chest dogs ( fig. 5 ). The coaxial cable was 0.5 cm in diameter and the active detector surface of this device was 7 mm2. The aluminium housing and Mylar effectively isolated the detector from the pulsating, moist heart. No interference from motion, light, noise, or moisture was observed. The measured background rate for the probe was less than 1 cpm/cm2.
The thin, active detection region of this device (75 ,) and the characteristics of silicon effectively minimized detection of high-penetrating gamma rays. The intrinsic photon efficiency of the device was calculated as 99% at 5 keV and 35% at 10 keV with a rapid fall off above this level ( fig. 6 ). This rapid decrease in efficiency for higher energies minimized detection of high-penetrating radiation. The experi- 
Detection Limits
The radiation type, the energy and the yield for commonly used radionuclides are summarized in table 1. In the case of l33Xe, the short-range component consists of L x-rays (4 keV) and beta rays (maximum energy 350 keV). These emissions have an effective range in heart tissue of about 0.5 mm. The volume monitored with these radiations is about 0.004 cm3.
Xenon-133 also emits K x-rays (30 keV) and a gamma ray (81 keV). Since the avalanche detector efficiency for the K x-rays is significantly greater, the gamma ray contribution is negligible. The effective detection volume for the K x-rays was estimated as approximately 0.5 cm3, and is largely determined by the collimator geometry. The detector efficiency as a function of distance is shown in figure 7 . At 0.6 cm, less than 10% of the radiation was detected. The capability of the detector to measure radiation intensity decreased as an exponential function. Assuming a volume approximated by a hemisphere, the actual volume detected with '33Xe was about 0.5 cm3. This corresponded to estimates based on the efficiency of the device and the known emissions of 133Xe.
Regional Blood Flow Calculations: Reliability A typical washout curve is shown in figure 8 . In 60 measurements, the clearance of 133Xe was described by a monoexponential equation with a correlation coefficient of 0.96 ± 0.02. Repetitive measurements of blood flow during steady hemodynamics conditions and various degrees of coronary obstruction were reproducible. With complete occlusion regional flow averaged 3 ± 4 ml/min/100 g (five measurements), severe occlusion 15 ± 6 ml/min/100 g (10 measurements), moderate occlusion 50 ± 8 ml/min/ 100 g (15 measurements) and no occlusion 75 ± 7 ml/min/100 g (15 measurements).
We calculated regional myocrardial blood flow DISTANCE FROM SOURCE,cm FIGURE 7 . Detector efficiency as a function of distance from a radiation point source. The capability of the detector to measure radiation intensity decreased as an exponential function. At 0.6 cm, less than 10% of the radiation detected directly over the radiation source was measured.
from the washout curves both from peak and from 85% of peak radioactivity. However, the difference between the two methods of analysis was not significantly different (r = 0.99). With this technology, radionuclides with beta emissions are efficiently detected and the limited range of the charged particles emitted by such isotopes defines the effective volume. For example, with krypton-85 (beta, maximum energy 700 keV), the effective range is 1 mm and the corresponding detection volume is located near the surface and is about 0.007 cm8. The gamma radiation from krypton-85 is of low-yield (0.4%) and high-energy (500 keV) and does not significantly contribute to the measured radiation. These calculations are based on the known radiation spectrum of krypton-85, the density of tissue, and the efficiency of the instrument.
Metabolic substrates labeled with radionuclides, such as carbon-14, sulfur-35 and calcium-45, retain their biochemical nature and can be efficiently detected with avalanche radiation detectors, so these devices might be useful for the study of in vivo cellular metabolism. Highly regional detection of cancer may be feasible with select radiotracers and avalanche detectors. Further miniaturization may yield cathetersize devices with multiple experimental and clinical uses.
The highest precision with external counting available is from positron-emitting radionuclides and transaxial tomography."-13 The simultaneous detection of high-energy photons travelling in opposite directions after the annhilation of positrons yields a precise localization of the source of radiation, and with computer reconstruction, three-dimensional images. However, these techniques are expensive, limited to centers with vast resources, and have not been applied for the quantitative determination of rapidly changing regional blood flow in vivo in volumes as small as is possible with the avalanche detectors. Measurement of regional blood flow with positronemission tomography is limited by the speed of data acquisition.'3 On the other hand, avalanche detectors are suitable for directly measuring positrons before annhilation, and therefore, the study of metabolism or flow using cyclotron-generated radioisotopes is possible with avalanche detectors.
Avalanche radiation detectors, with their solid-state stability, highly regionalized capabilities, ease of use, and potential for miniaturization, represent a new generation of radiation detectors. This first-generation probe measures primarily epicardial flow. With further miniaturization and refinements of technology, probes may be constructed that are suitable for endocardial blood flow determination. A complete study of the entire arterial tree is now feasible. Proximal flow can be measured with electromagnetic meters, more distal flow with Doppler devices, and now highly regionalized tissue perfusion may be determined by avalanche radiation detectors with diffusible indicators.
In this study we used the enhanced spatial resolution offered by low-penetrating radiation to measure the origin of radiations in vivo. This technology has allowed us to obtain reliable, valid measurements of regional myocardial blood flow in small volumes in vivo under the conditions tested. Further studies of coronary autoregulation with avalanche detectors in animal models and man, in disease and normal states, are now feasible.
